Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$1.86+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $5.20MP/E –Yield –

Processa Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Processa Pharmaceuticals's total debt was $230.00K at Dec 31, 2018. For fiscal 2018 it was $230.00K, down 90.6% from the year before.

Period	Period end	Value	Change
FY2018	Dec 31, 2018	$230.00K	-90.6%
FY2017	Dec 31, 2017	$2.45M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2018	Dec 31, 2018	$230.00K	–
Q4 FY2017	Dec 31, 2017	$2.45M	–

See a number that looks wrong?